New TB Drug Shows Hope For Mental Illness Treatment
A Friday report from Drs. Max Lurie and Harry M. Salzer at the American Medical Association convention describes isoniazid, a tuberculosis drug, producing marked improvements in 28 of 41 mental patients with anxiety, depression, and related conditions. Doses of 110 milligrams after meals yielded notable gains after months of therapy, including a 32-year-old woman resuming work and a 71-year-old woman lifting long-standing depressions. The study notes prior treatments failed for many, with patients aged 26 to 76 and encompassing manic depressive psychosis, psychoneurosis, agitated depressions, and pure anxiety. Further research into the drug’s mechanism continues.